Harvard Bioscience Schedules Second Quarter 2025 Earnings Conference Call for August 11, 2025 at 8:00 AM ET
Rhea-AI Summary
Harvard Bioscience (Nasdaq: HBIO) has scheduled its second quarter 2025 earnings conference call for August 11, 2025, at 8:00 AM ET. The company will release its financial results for the quarter ended June 30, 2025, before the market opens on the same day.
Interested participants who wish to ask questions during the call must pre-register to receive dial-in numbers and a unique PIN. An audio-only webcast option is also available through the company's investor website. The earnings release and related presentation materials will be accessible through Harvard Bioscience's Investor Relations section.
Positive
- None.
Negative
- None.
News Market Reaction – HBIO
On the day this news was published, HBIO gained 10.89%, reflecting a significant positive market reaction. Argus tracked a peak move of +6.9% during that session. Our momentum scanner triggered 17 alerts that day, indicating notable trading interest and price volatility. This price movement added approximately $2M to the company's valuation, bringing the market cap to $22M at that time.
Data tracked by StockTitan Argus on the day of publication.
HOLLISTON, Mass., Aug. 04, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for the quarter ended June 30, 2025, before the market opens on August 11, 2025, and will hold a conference call to discuss the results at 8:00 a.m. Eastern Time.
Participants who would like to join the call and ask a question must register here. Once registered, you will receive the dial-in numbers and a unique PIN number.
Participants who would like to join the audio-only webcast should go to our events and presentations on the investor website here.
Financial information presented on the call, including the earnings release and a related slide presentation, will be available on the Investor Relations section of Harvard Bioscience’s website.
About Harvard Bioscience
Harvard Bioscience, Inc. is a leading developer, manufacturer and seller of technologies, products and services that enable fundamental advances in life science applications, including research, drug and therapy discovery, bio-production and preclinical testing for pharmaceutical and therapy development. Our customers range from renowned academic institutions and government laboratories to the world’s leading pharmaceutical, biotechnology and contract research organizations. With operations in the United States, Europe, and China, we sell through a combination of direct and distribution channels to customers around the world.
For more information, please visit our website at www.harvardbioscience.com.
Investor Inquiries:
(508) 893-3120
investors@harvardbioscience.com
FAQ
When is Harvard Bioscience (HBIO) releasing Q2 2025 earnings?
How can investors join the Harvard Bioscience Q2 2025 earnings call?
Where can I find Harvard Bioscience's Q2 2025 earnings materials?
What period will Harvard Bioscience's Q2 2025 earnings cover?
